siRNA, Anti-MED19, 2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT61620WQ-2OMe)

The product SIRGT61620WQ-2OMe is a type of small interfering RNA (siRNA) that targets MED19 gene and regulates the expression of gene. The siRNA interferes with the expression of MED19 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001317078.1
Alternative Names DT2P1G7; LCMR1; MED19AS
Related Diseases Breast Lipoma
Purification HPLC
Target Gene
Gene ID 219541
Uniprot ID A0JLT2
Sub Cat Target Species Modification Scale  
SIRGT63620WQ-2MOE MED19 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT61620WQ-RB MED19 Human Ribo-modified Inquiry
SIRGT62620WQ-BB MED19 Human Backbone-modified Inquiry

Related Products